New study reveals how genes can alter the cancer-fighting power of fruits and fiber

FHS
May 22, 2024
4:20 am

A study in eBioMedicine uncovers two genetic loci that modify the impact of fiber and fruit intake on colorectal cancer risk, highlighting gene-diet interactions.

FDA awarded record number of review designations to CRISPR drugs in 2023 – Pharmaceutical Technology

Share this article In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gaining the first FDA approval for a CRISPR-based drug, exagamglogene autotemcel

January 31, 2024

CLN-619 by Cullinan Therapeutics for Refractory Multiple Myeloma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

January 6, 2025

Merck, Daiichi Sankyo to partner on targeted chemotherapy drugs in deal worth up to $22 billion

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.